Representative before the EPO

Technology company logo thumb
no operation time available
3 offices
Technology Company

We have observed 6 EP applications Julia Anne Florence has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after October 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP13803046

COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS

IPC classification:
A61K 47/38, A61K 31/58, A61K 31/4418, A61K 9/10, A61K 9/00
Applicant:
Glaxo Group Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15172604

DRY POWDER INHALATION DRUG PRODUCTS EXHIBITING MOISTURE CONTROL PROPERTIES AND METHODS OF ADMINISTERING THE SAME

IPC classification:
A61K 31/133, A61K 31/137, A61P 11/06, A61K 31/58, A61K 9/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12744272

CATHEPSIN C INHIBITORS

IPC classification:
C07D 405/12, C07D 309/14, A61K 31/35, A01N 43/16
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15794976

LONG ACTING PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C

IPC classification:
C12N 15/113, A61K 31/343, A61K 47/32, A61K 47/26, A61K 9/00
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
Request for examination was made
EP15791372

LONG ACTING PHARMACEUTICAL COMPOSITIONS FOR HEPATITIS C

IPC classification:
A61K 31/69, A61K 31/343, A61K 47/26, A61K 9/00, A61P 31/14, A61K 31/7088, C12N 15/113
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
Request for examination was made
EP15791373

COMBINATION LONG ACTING COMPOSITIONS AND METHODS FOR HEPATITIS C

IPC classification:
A61P 31/14, A61K 31/7088, A61K 47/26, A61K 9/00, C12N 15/113
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Julia Anne Florence, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature